View in EDS HTML Full Text PDF Full Text

Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureus Bacteremia.

Saved in:
Bibliographic Details
Title: Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureus Bacteremia.
Authors: Chan LC; Harbor-UCLA Medical Center, Division of Molecular Medicine, Torrance, CA 90502, USA.; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA.; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA., Lee HK; Harbor-UCLA Medical Center, Division of Molecular Medicine, Torrance, CA 90502, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA., Wang L; Harbor-UCLA Medical Center, Division of Molecular Medicine, Torrance, CA 90502, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA., Wang H; Harbor-UCLA Medical Center, Division of Molecular Medicine, Torrance, CA 90502, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA., Filler SG; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA.; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA., Ciranna A; Division of Infectious Diseases and International Health, Department of Medicine, Duke University School of Medicine, Durham, NC 27708, USA., Abdelhady W; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA., Xiong YQ; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA.; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA., Li L; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA., Gonzales RA; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA., Ruffin F; Division of Infectious Diseases and International Health, Department of Medicine, Duke University School of Medicine, Durham, NC 27708, USA., Fowler VG Jr; Division of Infectious Diseases and International Health, Department of Medicine, Duke University School of Medicine, Durham, NC 27708, USA.; Duke Clinical Research Institute, Durham, NC 27708, USA., Bayer AS; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA.; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA., Proctor RA; School of Medicine and Public Health, University of Wisconsin, Madison, WI 53726, USA., Yeaman MR; Harbor-UCLA Medical Center, Division of Molecular Medicine, Torrance, CA 90502, USA.; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA.; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA.
Corporate Authors: MRSA Systems Immunobiology Group (MSIG)
Source: Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2026 Mar 25; Vol. 15 (4). Date of Electronic Publication: 2026 Mar 25.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101637404 Publication Model: Electronic Cited Medium: Print ISSN: 2079-6382 (Print) Linking ISSN: 20796382 NLM ISO Abbreviation: Antibiotics (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42041295
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureus Bacteremia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chan+LC%22">Chan LC</searchLink>; Harbor-UCLA Medical Center, Division of Molecular Medicine, Torrance, CA 90502, USA.; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA.; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA.<br /><searchLink fieldCode="AU" term="%22Lee+HK%22">Lee HK</searchLink>; Harbor-UCLA Medical Center, Division of Molecular Medicine, Torrance, CA 90502, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Harbor-UCLA Medical Center, Division of Molecular Medicine, Torrance, CA 90502, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA.<br /><searchLink fieldCode="AU" term="%22Wang+H%22">Wang H</searchLink>; Harbor-UCLA Medical Center, Division of Molecular Medicine, Torrance, CA 90502, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA.<br /><searchLink fieldCode="AU" term="%22Filler+SG%22">Filler SG</searchLink>; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA.; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA.<br /><searchLink fieldCode="AU" term="%22Ciranna+A%22">Ciranna A</searchLink>; Division of Infectious Diseases and International Health, Department of Medicine, Duke University School of Medicine, Durham, NC 27708, USA.<br /><searchLink fieldCode="AU" term="%22Abdelhady+W%22">Abdelhady W</searchLink>; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA.<br /><searchLink fieldCode="AU" term="%22Xiong+YQ%22">Xiong YQ</searchLink>; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA.; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA.<br /><searchLink fieldCode="AU" term="%22Li+L%22">Li L</searchLink>; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA.<br /><searchLink fieldCode="AU" term="%22Gonzales+RA%22">Gonzales RA</searchLink>; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA.<br /><searchLink fieldCode="AU" term="%22Ruffin+F%22">Ruffin F</searchLink>; Division of Infectious Diseases and International Health, Department of Medicine, Duke University School of Medicine, Durham, NC 27708, USA.<br /><searchLink fieldCode="AU" term="%22Fowler+VG+Jr%22">Fowler VG Jr</searchLink>; Division of Infectious Diseases and International Health, Department of Medicine, Duke University School of Medicine, Durham, NC 27708, USA.; Duke Clinical Research Institute, Durham, NC 27708, USA.<br /><searchLink fieldCode="AU" term="%22Bayer+AS%22">Bayer AS</searchLink>; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA.; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA.<br /><searchLink fieldCode="AU" term="%22Proctor+RA%22">Proctor RA</searchLink>; School of Medicine and Public Health, University of Wisconsin, Madison, WI 53726, USA.<br /><searchLink fieldCode="AU" term="%22Yeaman+MR%22">Yeaman MR</searchLink>; Harbor-UCLA Medical Center, Division of Molecular Medicine, Torrance, CA 90502, USA.; Harbor-UCLA Medical Center, Division of Infectious Diseases, Torrance, CA 90502, USA.; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Institute for Infection and Immunity, Torrance, CA 90502, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22MRSA+Systems+Immunobiology+Group+%28MSIG%29%22">MRSA Systems Immunobiology Group (MSIG)</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101637404%22">Antibiotics (Basel, Switzerland)</searchLink> [Antibiotics (Basel)] 2026 Mar 25; Vol. 15 (4). <i>Date of Electronic Publication: </i>2026 Mar 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI+AG%22">MDPI AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101637404 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2079-6382 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220796382%22">20796382 </searchLink><i>NLM ISO Abbreviation: </i>Antibiotics (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42041295
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/antibiotics15040332
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureus Bacteremia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chan LC
      – PersonEntity:
          Name:
            NameFull: Lee HK
      – PersonEntity:
          Name:
            NameFull: Wang L
      – PersonEntity:
          Name:
            NameFull: Wang H
      – PersonEntity:
          Name:
            NameFull: Filler SG
      – PersonEntity:
          Name:
            NameFull: Ciranna A
      – PersonEntity:
          Name:
            NameFull: Abdelhady W
      – PersonEntity:
          Name:
            NameFull: Xiong YQ
      – PersonEntity:
          Name:
            NameFull: Li L
      – PersonEntity:
          Name:
            NameFull: Gonzales RA
      – PersonEntity:
          Name:
            NameFull: Ruffin F
      – PersonEntity:
          Name:
            NameFull: Fowler VG Jr
      – PersonEntity:
          Name:
            NameFull: Bayer AS
      – PersonEntity:
          Name:
            NameFull: Proctor RA
      – PersonEntity:
          Name:
            NameFull: Yeaman MR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 03
              Text: 2026 Mar 25
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2079-6382
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Antibiotics (Basel, Switzerland)
              Type: main
ResultId 1